This Exchange Traded Fund (ETF) employs a systematic approach designed to generate long-term capital appreciation. It achieves this by creating a concentrated portfolio of 50 companies from the S&P 500 index. The selection process prioritizes firms that are leaders in Research & Development (R&D) spending, with an additional critical screen for the quality of their Free Cash Flow (FCF).

Regeneron Pharmaceuticals, Inc.

Incyte Corporation

Vertex Pharmaceuticals Incorporated

Workday, Inc.

Cadence Design Systems, Inc.

Synopsys, Inc.

Eli Lilly and Company

Veeva Systems Inc.

Autodesk, Inc.

Meta Platforms, Inc.

Technology

Healthcare

Consumer Cyclical

Communication Services

Pacer S&P 500 Quality FCF R&D Leaders ETF

QFRD Holdings & Sector Breakdown